[go: up one dir, main page]

BR9913490A - Cyclic prosaposine and its uses - Google Patents

Cyclic prosaposine and its uses

Info

Publication number
BR9913490A
BR9913490A BR9913490-0A BR9913490A BR9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A
Authority
BR
Brazil
Prior art keywords
cyclic
prosaposine
derived
peptides
saposin
Prior art date
Application number
BR9913490-0A
Other languages
Portuguese (pt)
Inventor
David E Wright
John
S O'obrien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos Corp filed Critical Myelos Corp
Publication of BR9913490A publication Critical patent/BR9913490A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PEPTìDIOS DERIVADOS DE PROSAPOSINA CìCLICOS E SEUS USOS" A invenção se refere a peptídios cíclicos derivados de saposina C que apresentam efeitos neurotróficos e analgésicos."CYCLIC PROSAPOSIN DERIVED PEPTIDES AND THEIR USES" The invention relates to cyclic peptides derived from saposin C that have neurotrophic and analgesic effects.

BR9913490-0A 1998-08-28 1999-08-20 Cyclic prosaposine and its uses BR9913490A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9835998P 1998-08-28 1998-08-28
PCT/US1999/019378 WO2000012553A1 (en) 1998-08-28 1999-08-20 Cyclic prosaposin-derived peptides and uses thereof

Publications (1)

Publication Number Publication Date
BR9913490A true BR9913490A (en) 2001-09-25

Family

ID=22268937

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913490-0A BR9913490A (en) 1998-08-28 1999-08-20 Cyclic prosaposine and its uses

Country Status (13)

Country Link
EP (1) EP1105420A1 (en)
JP (2) JP4528443B2 (en)
KR (1) KR20010079695A (en)
CN (1) CN1324367A (en)
AU (1) AU751034B2 (en)
BR (1) BR9913490A (en)
CA (1) CA2341810A1 (en)
CZ (1) CZ2001655A3 (en)
HU (1) HUP0103265A3 (en)
IL (1) IL141586A0 (en)
PL (1) PL204359B1 (en)
WO (1) WO2000012553A1 (en)
ZA (1) ZA200102489B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
BR9913490A (en) * 1998-08-28 2001-09-25 Myelos Corp Cyclic prosaposine and its uses
AUPQ084899A0 (en) * 1999-06-08 1999-07-01 University Of Melbourne, The Neurotrophin agonists
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (en) * 2003-04-28 2008-02-06 常州南云科技有限公司 Saposin C-DOPS: A new anticancer drug
US9271932B2 (en) 2006-04-28 2016-03-01 Children's Hospital Medical Center Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems
WO2008051818A2 (en) * 2006-10-20 2008-05-02 Children's Hospital Medical Center Spontaneously forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (en) * 2013-06-14 2014-10-29 四川合泰新光生物科技有限公司 Analgesic peptide FI as well as genes and application thereof
BR112017022021B1 (en) 2015-04-23 2021-07-06 The Procter & Gamble Company HAIR TREATMENT COMPOSITION
EP3423031B1 (en) 2016-03-03 2021-09-08 The Procter & Gamble Company Aerosol antidandruff composition
EP3528899B1 (en) 2016-10-21 2024-04-10 The Procter & Gamble Company Dosage of foam for delivering consumer desired dosage volume and surfactant amount in an optimal formulation space
EP3528898A1 (en) 2016-10-21 2019-08-28 The Procter and Gamble Company Concentrated shampoo dosage of foam designating hair conditioning benefits
CN109843383A (en) 2016-10-21 2019-06-04 宝洁公司 For delivering the foam of the desired dose volume of consumer, amount of surfactant and scalp health dosage in optimal formulation space
US11129783B2 (en) 2016-10-21 2021-09-28 The Procter And Gamble Plaza Stable compact shampoo products with low viscosity and viscosity reducing agent
US20180110688A1 (en) 2016-10-21 2018-04-26 The Procter & Gamble Company Concentrated Shampoo Dosage of Foam for Providing Hair Care Benefits
EP3528895A1 (en) 2016-10-21 2019-08-28 The Procter & Gamble Company Concentrated shampoo dosage of foam for providing hair care benefits
US11141361B2 (en) 2016-10-21 2021-10-12 The Procter And Gamble Plaza Concentrated shampoo dosage of foam designating hair volume benefits
US11679073B2 (en) 2017-06-06 2023-06-20 The Procter & Gamble Company Hair compositions providing improved in-use wet feel
US11141370B2 (en) 2017-06-06 2021-10-12 The Procter And Gamble Company Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
US11224567B2 (en) 2017-06-06 2022-01-18 The Procter And Gamble Company Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
CN111201010A (en) 2017-10-10 2020-05-26 宝洁公司 Method for treating hair or skin with a personal care composition in foam form
JP2020536876A (en) 2017-10-10 2020-12-17 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ Compact shampoo composition containing amino acid-based anionic surfactant and cationic polymer
WO2019074989A1 (en) 2017-10-10 2019-04-18 The Procter & Gamble Company Compact shampoo composition containing sulfate-free surfactants
EP3694607B1 (en) 2017-10-10 2022-12-28 The Procter & Gamble Company Compact shampoo composition
US10912732B2 (en) 2017-12-20 2021-02-09 The Procter And Gamble Company Clear shampoo composition containing silicone polymers
EP3813774A1 (en) 2018-06-29 2021-05-05 The Procter & Gamble Company Low surfactant aerosol antidandruff composition
US12226505B2 (en) 2018-10-25 2025-02-18 The Procter & Gamble Company Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents
US11980679B2 (en) 2019-12-06 2024-05-14 The Procter & Gamble Company Sulfate free composition with enhanced deposition of scalp active
EP4110474A1 (en) 2020-02-27 2023-01-04 The Procter & Gamble Company Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics
CA3198853A1 (en) 2020-11-23 2022-05-27 The Procter & Gamble Company Personal care compositions free of sulfated surfactants
CN116568263A (en) 2020-12-04 2023-08-08 宝洁公司 Hair care composition comprising malodor reducing material
US11771635B2 (en) 2021-05-14 2023-10-03 The Procter & Gamble Company Shampoo composition
US11986543B2 (en) 2021-06-01 2024-05-21 The Procter & Gamble Company Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants
JP2024544222A (en) 2021-12-09 2024-11-28 ザ プロクター アンド ギャンブル カンパニー Sulfate-free personal cleansing composition with effective preservative properties - Patents.com

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106106A0 (en) * 1993-06-22 1993-10-20 Interpharm Lab Ltd Library of polymeric molecules and its preparation
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
BR9913490A (en) * 1998-08-28 2001-09-25 Myelos Corp Cyclic prosaposine and its uses

Also Published As

Publication number Publication date
CA2341810A1 (en) 2000-03-09
WO2000012553A1 (en) 2000-03-09
AU5690599A (en) 2000-03-21
PL204359B1 (en) 2010-01-29
KR20010079695A (en) 2001-08-22
JP4528443B2 (en) 2010-08-18
JP2002523518A (en) 2002-07-30
IL141586A0 (en) 2002-03-10
HUP0103265A3 (en) 2002-09-30
JP2010150272A (en) 2010-07-08
HUP0103265A2 (en) 2002-02-28
CN1324367A (en) 2001-11-28
AU751034B2 (en) 2002-08-08
EP1105420A1 (en) 2001-06-13
PL346346A1 (en) 2002-02-11
CZ2001655A3 (en) 2001-11-14
ZA200102489B (en) 2002-06-04

Similar Documents

Publication Publication Date Title
BR9913490A (en) Cyclic prosaposine and its uses
EP0624348A3 (en) Bipolar electrosurgical instruments.
EP0600470A3 (en) Bipolar membrane.
NO20012774D0 (en) Preparation and method using essential plant oils
DE69927956D1 (en) SHAMPOO COMPOSITIONS BASED ON SILICONE
FI955866A0 (en) Rinse-off water-in-water compositions
ITRM960810A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS OR MACROLIDS
ATE289640T1 (en) AMIDOFUNCTIONAL AMINOPOLYDIORGANOSILOXANES
DE69210683D1 (en) Endoscopic, bipolar electrosurgical instruments
BR0109943A (en) Pharmaceutical Compositions
ES2081870T3 (en) PLASTO-ELASTIC POLYPROPYLENE COMPOSITIONS.
PT817847E (en) IL-17 RECEPTOR
DE69730092D1 (en) Photocrosslinkable silicone compositions
DE69723277D1 (en) Vapor Sterilization Indicating Compositions
EP0657942A3 (en) Lateral bipolar transistor.
ITTO930346A0 (en) PROCEDURE FOR THE PREPARATION OF TAUROCHOLANE DERIVATIVES.
ES2170143T3 (en) COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM.
ES2132556T3 (en) NEW DERIVATIVE OF BENZO-TIADIAZINA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
MX9204623A (en) COMPOSITE OF BIS-4-PIPERIDIL-PHOSPHITE N-METHYLATED.
GT199900062A (en) EFFERVESCENT PREPARATIONS.
BG100248A (en) SQUALENSENTEZA INHIBITORS
DK0977871T3 (en) Neurotrypsin
IT1303736B1 (en) PEPTIDES DERIVED FROM RANTES WITH ANTI-HIV ACTIVITY.
IL139531A0 (en) Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same
PT633928E (en) MICRORGANISMS PREPARATION AND USES PROCESS

Legal Events

Date Code Title Description
PC Transfer

Free format text: MYLS ACQUISITIONS CORP (US)

TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.